2nd November 2026, Monday

TechPharus

Latest Posts

HealthTech News

  • Long-term study finds modern hormone replacement therapy not linked to heart disease risk
    on November 2, 2026 at 9:00 am

    Contemporary hormone replacement therapy (HRT) was not associated with an increased risk of heart attack, stroke, blood clots or death among women ages 45 to 59, according to a large, long-term study of more than 52,000 women in Israel. The findings from this independent, preliminary research will be presented at the American Heart Association’s Scientific Sessions 2026. The meeting is Nov. 6–9 in Chicago.

  • Rural residents face nearly three times higher risk of heart attack death before reaching a hospital
    on November 2, 2026 at 9:00 am

    People living in rural areas who experienced a heart attack were nearly three times more likely to die before reaching hospital care, compared with those living in large metropolitan areas, according to new, independent, preliminary research presented at the American Heart Association’s Scientific Sessions 2026, held Nov. 6–9 in Chicago.

  • Single blood protein stands out among 30 tests for assessing fatty liver disease
    on November 2, 2026 at 1:30 am

    The reliable assessment of metabolic dysfunction-associated steatotic liver disease (MASLD) is crucial for determining the stage of the disease, initiating appropriate treatments and monitoring the course of therapy. To date, a liver biopsy has often been necessary for this purpose. In this invasive procedure, a tissue sample is taken and examined.

  • Tumor index can identify breast cancer patients’ drug response
    on November 1, 2026 at 10:00 pm

    Researchers at The Hong Kong Polytechnic University (PolyU) have developed an imaging biomarker, the Tumour Heterogeneity Index (THI), which enables noninvasive assessment of breast cancer patients’ response to AKT inhibitors before treatment, helping clinicians identify patients most likely to benefit from therapy. The study found that patients with a high THI achieved an estimated pathological complete response (pCR) rate of 56.1%, significantly higher than that of patients with a low THI. The technology could help patients receive the most appropriate treatment at an earlier stage, reduce unnecessary side effects and enable clinicians to better tailor treatment strategies to individual patients.

  • Vision-language AI agent could help radiologists interpret ultrasounds faster and more accurately
    on November 1, 2026 at 5:00 pm

    When a patient arrives in the emergency department with severe abdominal pain, every minute counts. Researchers at the University of Colorado Anschutz School of Medicine are investigating ways to streamline the work of radiologists and make it more efficient. They also aim to quickly identify patients who may need urgent surgery and speed up the path to treatment.